Salivary glands of the sand fly Phlebotomus papatasi contain pharmacologically active amounts of adenosine and 5'-AMP

Journal of Experimental Biology

Volumn 202, Issue 11, 1999, Pages 1551-1559

  Ribeiro, José M C ^a   Katz, Oren ^b   Pannell, Lewis K ^c   Waitumbi, John ^b,d   Warburg, Alon ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d U S ARMY   (United States)

Author keywords

Adenosine; AMP; Aorta; Bioassay; Electrospray mass spectrometry; Haemostasis; HPLC; Phlebotomus papatasi; Phosphorylase a; Platelet; Protein phosphatase; Sand fly

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; ANTITHROMBOCYTIC AGENT; ENZYME INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE; VASODILATOR AGENT;

ANIMAL; ARTICLE; BIOASSAY; BLOOD; C3H MOUSE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; FOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; METABOLISM; MOUSE; PHLEBOTOMUS; RABBIT; SALIVARY GLAND; SECRETION;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; BIOLOGICAL ASSAY; BLOOD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; FEMALE; FOOD; MACROPHAGES; MASS SPECTROMETRY; MICE; MICE, INBRED C3H; PHLEBOTOMUS; PHOSPHOPROTEIN PHOSPHATASE; PLATELET AGGREGATION INHIBITORS; RABBITS; SALIVARY GLANDS; VASODILATOR AGENTS;

EID: 0033152272     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adler, S. and Theodor, O. (1926). The mouthparts, alimentary tract and salivary apparatus of the female Phlebotomus papatasi. Ann. Trop. Med. Parasitol. 20, 109-142.
2. Apasov, S., Koshiba, M., Redegeld, F. and Sitkovsky, M. V. (1995). Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol Rev. 146, 5-19.
3. Bednar, B. C. C., Gould, R. J. and Connolly, T. M. (1995). Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists. Thromb. Res. 77, 453-463.
4. Bot, G. and Dosa, I. (1971). The influence of effectors modifying phosphorylase-a in the phosphorylase phosphatase reaction. Acta Biochim. Biophys. Acad. Scient. Hung. 6, 73-87.
5. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Analyt. Biochem. 72, 248-254.
6. Champagne, D. E. (1994). The role of salivary vasodilators in bloodfeeding and parasite transmission. Parasitol. Today 10, 430-433.
7. Collis, M. G. (1989). The vasodilator role of adenosine. Pharmac. Ther. 41, 143-162.
8. Dionisotti, S., Zocchi, C., Varani, K., Borea, P. A. and Ongini, E. (1992). Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn Schmiedebergs Arch. Pharmac. 346, 673-676.
9. Dong, Z. Y. X., Xie, K., Juang, S. H., Liansa, N. and Fidler, I. J. (1995). Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatase 1 and 2A. J. Leuk. Biol. 58, 725-732.
10. Edlund, A., Siden, A. and Sollevi, A. (1987). Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole. Thromb. Res. 45, 183-190.
11. Farkas, I., Toth, B. and Gergely, P. (1988). Regulation of the dephosphorylation of phosphorylase A by glucose, AMP and polyamines. Int. J. Biochem. 20, 197-201.
12. Gordon, J. L. and Martin, W. (1983). Endothelium-dependent relaxation of the pig aorta: relationship to stimulation of 86Rb efflux from isolated endothelial cells. Br. J. Pharmac. 79, 531-541.
13. Gutierrez Merino, C., Garcia Blanco, F., Pocovi, M., Menendez, M. and Laynez, J. (1980). Regulation of phosphorylase b by AMP. The effects of enzyme concentration. J. Biochem. 87, 1483-1490.
14. Hasko, G., Szabo, C., Nemeth, Z. H., Kvetan, V., Pastores, S. M. and Vizi, E. S. (1996). Adenosine receptor agonists differentially regulate IL-10, TNF-alpha and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634-4640.
15. Hink, W. F., Romstedt, K. J., Burke, J. W., Doskotch, R. W. and Feller, D. R. (1989). Inhibition of human platelet aggregation and secretion by ant venom and a compound isolated from venom. Inflammation 13, 175-184.
16. Hon, W. M., Moochhala, S. and Khoo, H. E. (1997). Adenosine and its receptor agonists potentiate nitric oxide synthase expression induced by lipopolysaccharide in RAW 264 murine macrophages. Life Sci. 60, 1327-1235.
17. Hu, Y., Fisette, P. L., Denlinger, L. C., Guadarrama, A. G., Sommer, J. A., Proctor, R. A. and Bertics, P. J. (1998). Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 26 macrophages. J. Biol. Chem. 273, 27170-27175.
18. Lerner, E. A., Ribeiro, J. M. C., Nelson, R. J. and Lerner, M. R. (1991). Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J. Biol. Chem. 266, 11234-11236.
19. Lewis, C. D., Hourani, S. M., Long, C. J. and Collis, M. G. (1994). Characterization of adenosine receptors in the rat isolated aorta. Gen. Pharmac. 25, 1381-1387.
20. Modi, G. B. and Tesh, R. B. (1983). A simple technique for mass rearing Lutzomyia longipalpis and Phlebotomus papatasi (Diptera: Psychodidae) in the laboratory. J. Med. Ent. 20, 568-569.
21. Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1991). Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmac. Rev. 43, 109-142.
22. Qureshi, A. A. A. A., Ohnuma, M. T. M., Granstein, R. D. and Lerner, E. A. (1996). Immunomodulatory properties of maxadilan, the vasodilator peptide from sand fly salivary gland extracts. Am. J. Trop. Med. Hyg. 54, 665-671.
23. Ribeiro, J. M. C. (1995). Blood-feeding arthropods: Live syringes or invertebrate pharmacologists? Infect. Agents Dis. 4, 143-152.
24. Ribeiro, J. M. C., Rossignol, P. A. and Spielman, A. (1986). Blood finding strategy of a capillary feeding sandfly, Lutzomyia longipalpis. Camp. Biochem. Physiol. 83A, 683-686.
25. Rose'Meyer, R. B. and Hope, W. (1990). Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta. Br. J. Pharmac. 100, 576-580.
26. Seegmiller, J. E., Watanabe, T. and Schreier, M. H. (1977). The effect of adenosine on lymphoid cell proliferation and antibody formation. Ciba Found. Symp. 48, 249-276.
27. Soares, M. B., Titus, R. G., Shoemaker, C. B., David, J. R. and Bozza, M. (1998). The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. J. Immunol. 160, 1811-1816.
28. Theodos, C. M., Ribeiro, J. M. C. and Titus, R. G. (1991). Analyzis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect. Immun. 59, 1592-1598.
29. Titus, R. G. and Ribeiro, J. M. C. (1988). Salivary gland lysates of the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239, 1306-1308.
30. Urquhart, R. A. and Broadley, K. J. (1991). Comparison of adenosine receptor agonists with other vasodilators on noradrenaline-, potassium- and phorbol ester-contracted rabbit aorta. Eur. J. Pharmac. 200, 35-43.
31. Waitumbi, J. and Warburg, A. (1998). Phlebotomus papatasi saliva inhibits protein phosphatase activity and nitric oxide production by murine macrophages. Inf. Immun. 66, 1534-1537.
32. Warburg, A., Saraiva, E., Lanzaro, G. C., Titus, R. G. and Neva, F. (1994). Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Phil. Trans. R. Soc. Lund. B 345, 223-230.
33. Webster, H. K. (1984). Role of purines in lymphocyte function. Asian Pac. J. Allergy Immunol. 2, 311-317.
34. Webster, M. and Prado, E. S. (1970). Glandular kallikreins from horse and human urine and from hog pancreas. Meth. Enzymol. 19, 681-699.